News on Medial

AI, machine learning to help Indian pharma industry to pivot on innovation

Livemint · 27d

The Indian pharmaceutical industry is expected to undergo a profound transformation in 2025, driven by technological advancements such as AI, machine learning, and precision medicine. With a projected growth of nearly two-fold to USD 130 billion by 2030, the industry aims to position India as a global hub for high-quality, affordable pharmaceuticals. Innovation, wider global access, and improved quality are key themes for the future. The government is also expected to announce operational details of the Promotion of Research & Innovation Programme to further spur innovation. Strengthened regulatory frameworks and collaboration between stakeholders will drive the adoption of innovative therapies while prioritizing patient safety. The healthcare sector is also evolving to meet the diverse needs of the population, and the integration of advanced technologies such as AI, robotics, and telemedicine will enhance diagnostic precision and operational efficiency. The medtech sector must focus on R&D and innovation to sustain growth momentum, and the diagnostics industry is set to reach USD 25 billion by FY28 fueled by increasing awareness of preventive healthcare and broader insurance coverage. Embracing genomics, digitalization, and technologies like AI and data analytics will shape the future of diagnostics.